Stocktoria
Baird Medical Investment Holdings Ltd BDMD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-12-13
Baird Medical Investment Holdings Ltd financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $22.5M | $37.0M | $31.5M |
| Gross profit | $18.9M | $32.7M | $27.2M |
| R&D expense | $20.1M | $6.2M | $4.3M |
| Operating income | -$25.6M | $15.3M | $11.9M |
| Income tax | $1.2M | $1.5M | $1.7M |
| Net income | -$27.3M | $12.5M | $10.5M |
| EPS (diluted) | $-0.98 | $0.57 | $0.51 |
| Operating cash flow | -$1.3M | -$6.3M | -$1.0M |
| Free cash flow | -$1.4M | -$9.2M | -$3.7M |
| Cash & equivalents | $178,321 | $3.0M | — |
| Inventory | $1.1M | $1.3M | $1.1M |
| Total assets | $69.7M | $78.0M | $56.7M |
| Total liabilities | $38.5M | $38.2M | $21.0M |
| Shareholders' equity | $31.4M | $39.8M | $35.8M |
Source: SEC EDGAR filings · CIK 0001982444 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.